LINC00657

Species: Homo sapiens

Position: chr20: 36045617-36050960

Known as: NORAD , ENSG00000260032

Transcript: NR_027451 , ENST00000565493

Sequence: Download

Description:

We selected LINC00657 to determine their role in breast cancer, and found that LINC00657 knockout significantly suppresses tumor cell growth and proliferation, suggesting that it plays an oncogenic role. These results highlight the clinical significance of lncRNAs, and thus, the lncRNA may serve as prognostic markers for breast cancer.



sgRNAs

sgRNA_ID Sequence Position (Chr) Position (Lnc) Length PAM Type Validity Cell line Note Ref.
sgRNA1 TTCCGGTCCGGCAGAGATCG 36050939-36050958(-) gene body (near 5') 20 CGG CRISPRko Experimental validated LM-4142 paried with sgRNA2, known as NORAD [1]
sgRNA2 ACTCTATTCTACAAGCAACG 36045593-36045612(+) down stream 20 AGG CRISPRko Experimental validated LM-4142 paried with sgRNA1, known as NORAD [1]
sgRNA3 GTTGCGAAGAGCAAGCGGGG 36051117-36051136(-) up stream 20 TGG CRISPRa Experimental validated LCLs known as NORAD [2]
sgRNA4 TCTGCAATGTTCCGGCGTGG 36051044-36051064(+) up stream 20 GGG CRISPRa Experimental validated LCLs known as NORAD [2]

GBrowser


Links

lncRNA Function:

sgRNA Design Tool:

Reference

1. Liu H, Li J, Koirala P, Ding X, Chen B, et al. (2016). Long non-coding RNAs as prognostic markers in human breast cancer. Oncotarget 7(15): 20584-96.

2. Wang C, Li D, Zhang L, Jiang S, Liang J, et al. (2019). RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes. J Virol 93(13).